Ilmarinen Mutual Pension Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Ilmarinen Mutual Pension Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.8M	Hold	33,800	–	–	0.11%	98
2026 Q1	$15.1M	Sell	33,800 -5,000	-13%	-$2.33M	0.12%	108
2025 Q4	$17.6M	Hold	38,800	–	–	0.14%	89
2025 Q3	$15.2M	Sell	38,800 -6,000	-13%	-$2.51M	0.11%	97
2025 Q2	$19.9M	Buy	44,800 +11,500	+35%	+$5.3M	0.16%	80
2025 Q1	$16.1M	Buy	33,300 +5,000	+18%	+$2.33M	0.14%	86
2024 Q4	$11.4M	Buy	28,300 +8,800	+45%	+$4.08M	0.1%	116
2024 Q3	$9.07M	Hold	19,500	–	–	0.1%	106
2024 Q2	$9.14M	Hold	19,500	–	–	0.11%	96
2024 Q1	$8.15M	Hold	19,500	–	–	0.1%	113
2023 Q4	$7.93M	Hold	19,500	–	–	0.11%	112
2023 Q3	$6.78M	Hold	19,500	–	–	0.09%	123
2023 Q2	$6.86M	Hold	19,500	–	–	0.09%	132
2023 Q1	$6.14M	Sell	19,500 -8,500	-30%	-$2.55M	0.08%	130
2022 Q4	$8.09M	Hold	28,000	–	–	0.12%	100
2022 Q3	$8.11M	Hold	28,000	–	–	0.13%	84
2022 Q2	$7.89M	Hold	28,000	–	–	0.12%	89
2022 Q1	$7.31M	Hold	28,000	–	–	0.09%	114
2021 Q4	$6.15M	Hold	28,000	–	–	0.07%	135
2021 Q3	$5.08M	Hold	28,000	–	–	0.05%	150
2021 Q2	$5.65M	Hold	28,000	–	–	0.06%	143
2021 Q1	$6.02M	Hold	28,000	–	–	0.07%	139
2020 Q4	$6.62M	Buy	+28,000	New	+$6.42M	0.08%	122

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ilmarinen Mutual Pension Insurance's VRTX Position: Q2 2026 in Review

Ilmarinen Mutual Pension Insurance held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 33,800 shares worth $16.8M. The position accounts for 0.11% of the portfolio, ranked #98.

Ilmarinen Mutual Pension Insurance first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.9M in Q2 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Ilmarinen Mutual Pension Insurance held 33,800 shares of Vertex Pharmaceuticals worth $16.8M as of Q2 2026.
Ilmarinen Mutual Pension Insurance left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.11% of Ilmarinen Mutual Pension Insurance's portfolio in Q2 2026, its #98 holding.
Ilmarinen Mutual Pension Insurance first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Ilmarinen Mutual Pension Insurance's Vertex Pharmaceuticals position peaked at $19.9M in Q2 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ilmarinen Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.